Mark McHale
President chez Oak Hill Bio Corp.
Profil
Mark McHale is the founder of ASLAN Pharmaceuticals Pte Ltd.
(founded in 2010) and Aslan Pharmaceuticals Ltd.
(founded in 2010).
He held the title of Chief Scientific Officer at ASLAN Pharmaceuticals Pte Ltd.
and Chief Development Officer and Head-R&D at Aslan Pharmaceuticals Ltd.
Dr. McHale currently held the position of Director at Aslan Pharmaceuticals Taiwan Ltd.
and Aslan Pharmaceuticals (Shanghai) Co. Ltd.
He is also the Co-President & Director at Oak Hill Bio Corp.
(since 2022).
Dr. McHale's former positions include Principal at Smithkline Beecham Plc (1991-1997), Head-Molecular Sciences at AstraZeneca LP (1997-2010), and Principal at GlaxoSmithKline LLC (2001-2013).
Dr. McHale received his undergraduate degree from the University of London and his doctorate from the University of East Anglia.
Postes actifs de Mark McHale
| Sociétés | Poste | Début |
|---|---|---|
Aslan Pharmaceuticals Taiwan Ltd.
 Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The company is based in Taipei, Taiwan and was founded in 2014. | Directeur/Membre du Conseil | - |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. | Directeur/Membre du Conseil | - |
Oak Hill Bio Corp.
 Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | President | 12/04/2022 |
Anciens postes connus de Mark McHale
| Sociétés | Poste | Fin |
|---|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Fondateur | 31/05/2020 |
AstraZeneca LP
 AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | 01/01/2010 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | 01/06/1997 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
ASLAN Pharmaceuticals Pte Ltd.
 ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Fondateur | - |
Formation de Mark McHale
| University of London | Undergraduate Degree |
| University of East Anglia | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ASLAN PHARMACEUTICALS LIMITED | Health Technology |
| Entreprise privées | 7 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
ASLAN Pharmaceuticals Pte Ltd.
ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Health Technology |
Aslan Pharmaceuticals Taiwan Ltd.
Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The company is based in Taipei, Taiwan and was founded in 2014. | Health Technology |
| Aslan Pharmaceuticals (Shanghai) Co. Ltd. | |
Oak Hill Bio Corp.
Oak Hill Bio Corp. Miscellaneous Commercial ServicesCommercial Services Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA. | Commercial Services |
